Search Results - "FELDSTEIN, Ariel E"

Refine Results
  1. 1

    Liquid biopsy for liver diseases by Mann, Jelena, Reeves, Helen L, Feldstein, Ariel E

    Published in Gut (01-12-2018)
    “…With the growing number of novel therapeutic approaches for liver diseases, significant research efforts have been devoted to the development of liquid biopsy…”
    Get more information
    Journal Article
  2. 2
  3. 3

    NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice by Wree, Alexander, Eguchi, Akiko, McGeough, Matthew D., Pena, Carla A., Johnson, Casey D., Canbay, Ali, Hoffman, Hal M., Feldstein, Ariel E.

    Published in Hepatology (Baltimore, Md.) (01-03-2014)
    “…Inflammasome activation plays a central role in the development of drug‐induced and obesity‐associated liver disease. However, the sources and mechanisms of…”
    Get full text
    Journal Article
  4. 4

    Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223 by Calvente, Carolina Jimenez, Tameda, Masahiko, Johnson, Casey D, Del Pilar, Hana, Lin, Yun Chin, Adronikou, Nektaria, De Mollerat Du Jeu, Xavier, Llorente, Cristina, Boyer, Josh, Feldstein, Ariel E

    Published in The Journal of clinical investigation (01-10-2019)
    “…Persistent, unresolved inflammation in the liver represents a key trigger for hepatic injury and fibrosis in various liver diseases and is controlled by…”
    Get full text
    Journal Article
  5. 5

    Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH by Daemen, Sabine, Gainullina, Anastasiia, Kalugotla, Gowri, He, Li, Chan, Mandy M., Beals, Joseph W., Liss, Kim H., Klein, Samuel, Feldstein, Ariel E., Finck, Brian N., Artyomov, Maxim N., Schilling, Joel D.

    Published in Cell reports (Cambridge) (12-01-2021)
    “…Macrophage-mediated inflammation is critical in the pathogenesis of non-alcoholic steatohepatitis (NASH). Here, we describe that, with high-fat,…”
    Get full text
    Journal Article
  6. 6

    NLRP3 inflammasome activation is required for fibrosis development in NAFLD by Wree, Alexander, McGeough, Matthew D., Peña, Carla A., Schlattjan, Martin, Li, Hongying, Inzaugarat, Maria Eugenia, Messer, Karen, Canbay, Ali, Hoffman, Hal M., Feldstein, Ariel E.

    “…NLR inflammasomes, caspase 1 activation platforms critical for processing key pro-inflammatory cytokines, have been implicated in the development of…”
    Get full text
    Journal Article
  7. 7

    Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease by Povero, Davide, Eguchi, Akiko, Li, Hongying, Johnson, Casey D, Papouchado, Bettina G, Wree, Alexander, Messer, Karen, Feldstein, Ariel E

    Published in PloS one (03-12-2014)
    “…Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in both adult and children. Currently there are no reliable methods to…”
    Get full text
    Journal Article
  8. 8

    NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL‐17 and TNF in mice by Wree, Alexander, McGeough, Matthew D., Inzaugarat, Maria Eugenia, Eguchi, Akiko, Schuster, Susanne, Johnson, Casey D., Peña, Carla A., Geisler, Lukas J., Papouchado, Bettina G., Hoffman, Hal M., Feldstein, Ariel E.

    Published in Hepatology (Baltimore, Md.) (01-02-2018)
    “…The NLRP3 inflammasome, a caspase‐1 activation platform, plays a key role in the modulation of liver inflammation and fibrosis. Here, we tested the hypothesis…”
    Get full text
    Journal Article
  9. 9

    TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies by McGeough, Matthew D, Wree, Alexander, Inzaugarat, Maria E, Haimovich, Ariela, Johnson, Casey D, Peña, Carla A, Goldbach-Mansky, Raphaela, Broderick, Lori, Feldstein, Ariel E, Hoffman, Hal M

    Published in The Journal of clinical investigation (01-12-2017)
    “…The NLRP3 inflammasome is a protein complex responsible for caspase-1-dependent maturation of the proinflammatory cytokines IL-1β and IL-18. Gain-of-function…”
    Get full text
    Journal Article
  10. 10

    Circulating adipocyte-derived extracellular vesicles are novel markers of metabolic stress by Eguchi, Akiko, Lazic, Milos, Armando, Aaron M., Phillips, Susan A., Katebian, Roia, Maraka, Spyridoula, Quehenberger, Oswald, Sears, Dorothy D., Feldstein, Ariel E.

    “…We recently reported that stressed adipocytes release extracellular vesicles (EVs) that act as “find-me” signals to promote macrophage migration and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis by Dixon, Laura J, Flask, Chris A, Papouchado, Bettina G, Feldstein, Ariel E, Nagy, Laura E

    Published in PloS one (07-02-2013)
    “…Nonalcoholic steatohepatitis (NASH) is associated with caspase activation. However, a role for pro-inflammatory caspases or inflammasomes has not been explored…”
    Get full text
    Journal Article
  13. 13

    Novel Drivers of the Inflammatory Response in Liver Injury and Fibrosis by Wree, Alexander, Holtmann, Theresa Maria, Inzaugarat, Maria Eugenia, Feldstein, Ariel E

    Published in Seminars in liver disease (01-07-2019)
    “…Hepatocyte demise as well as signals released by stressed hepatocytes have been now recognized as important triggers of liver inflammation. While traditional…”
    Get more information
    Journal Article
  14. 14

    The role of oxidized lipid species in insulin resistance and NASH in children by Santoro, Nicola, Feldstein, Ariel E

    Published in Frontiers in endocrinology (Lausanne) (03-10-2022)
    “…During the last two decades, nonalcoholic fatty liver disease (NAFLD) has emerged as the most common hepatic disease in pediatrics, mainly owing to the rising…”
    Get full text
    Journal Article
  15. 15

    NLR Family Pyrin Domain‐Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice by Inzaugarat, Maria Eugenia, Johnson, Casey D., Holtmann, Theresa Maria, McGeough, Matthew D., Trautwein, Christian, Papouchado, Bettina G., Schwabe, Robert, Hoffman, Hal M., Wree, Alexander, Feldstein, Ariel E.

    Published in Hepatology (Baltimore, Md.) (01-02-2019)
    “…The NLR family pyrin domain‐containing 3 (NLRP3) inflammasome plays an important role in liver fibrosis (LF) development. However, the mechanisms involved in…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future by Wieckowska, Anna, McCullough, Arthur J., Feldstein, Ariel E.

    Published in Hepatology (Baltimore, Md.) (01-08-2007)
    “…Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, and its prevalence is increasing worldwide. It…”
    Get full text
    Journal Article
  18. 18

    Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice by Schuster, Susanne, Johnson, Casey D., Hennebelle, Marie, Holtmann, Theresa, Taha, Ameer Y., Kirpich, Irina A., Eguchi, Akiko, Ramsden, Christopher E., Papouchado, Bettina G., McClain, Craig J., Feldstein, Ariel E.

    Published in Journal of lipid research (01-09-2018)
    “…Circulating oxidized linoleic acid (LA) metabolites (OXLAMs) are increased in patients with nonalcoholic steatohepatitis (NASH) and their levels correlate with…”
    Get full text
    Journal Article
  19. 19

    Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications by Alkhouri, Naim, Carter-Kent, Christine, Feldstein, Ariel E

    “…Pathological increases in cell death in the liver as well as in peripheral tissues has emerged as an important mechanism involved in the development and…”
    Get more information
    Journal Article
  20. 20